Inside the FDA's Accelerated Approval: How it’s extending lives and improving patient care
Last week, OSP had the pleasure of speaking with Ginny Beakes-Read at the DIA Global conference.
Last week, OSP had the pleasure of speaking with Ginny Beakes-Read at the DIA Global conference.
Yesterday (June 24) Novo Nordisk unveiled plans to invest $4.1 billion (approximately €3.8 billion) in a new manufacturing facility in Clayton, North Carolina.